Document is current
Any future updates will be listed below
-
Authors
Marino, Emerson Cestari
Momesso, Denise
Toyoshima, Marcos Tadashi Kakitani
de Almeida, Maria Fernanda Ozorio
Schaan, Beatriz D.
Negretto, Leandra Anália Freitas
Santomauro Junior, Augusto Cezar
Cukier, Priscilla
Genestreti, Paulo Roberto Rizzo
Feitosa, Alina Coutinho Rodrigues
da Silva Soares Pinto, Jorge Eduardo
Ribeiro, Rogerio Silicani
Lamounier, Rodrigo Nunes
Lyra, Ruy
Bertoluci, Marcello Casaccia
- License Information
-
More Information
Article History
Received: 5 December 2024
Accepted: 10 January 2025
First Online: 12 February 2025
Declarations
:
: Not applicable.
: Not applicable.
: Emerson Cestari Marino receive fees for giving lectures or preparing educational materials from the companies: PTC Therapeutics, Novo Nordisk, Bracepharma and Supera. Ruy Lyra participates on the advisory board of Astrazeneca, Novo Nordisk, Lilly, Biolab, Mantecorp, Boehringer-Ingelheim, Bayer, Roche and P&G Priscilla Cukier participates in Novo Nordisk’s advisory board. Paulo Roberto Rizzo Genestreti receave fees related to advisory board from NovoNordisk, and Speakers from Novo Nordisk, Lilly and Boehringer-Ingelheim. All other authors declared no conflicts of interest.
